Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Notes Payables (2024 - 2025)

Historic Notes Payables for Basel Medical (BMGL) over the last 2 years, with Q2 2025 value amounting to $1.6 million.

  • Basel Medical's Notes Payables fell 1853.68% to $1.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.6 million, marking a year-over-year decrease of 1853.68%. This contributed to the annual value of $1.7 million for FY2025, which is 1663.04% down from last year.
  • Basel Medical's Notes Payables amounted to $1.6 million in Q2 2025, which was down 1853.68% from $2.0 million recorded in Q2 2024.
  • Basel Medical's 5-year Notes Payables high stood at $2.0 million for Q2 2024, and its period low was $1.6 million during Q2 2025.